<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_UNA_Honduras_project_immunology-of-dengue_html skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:UNA Honduras/project/immunology-of-dengue.html</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="art-main"><DIV class="art-sheet clearfix"><DIV class="art-layout-wrapper"><DIV class="art-content-layout"><DIV class="art-content-layout-row"><DIV class="art-layout-cell art-sidebar1"><DIV class="art-vmenublock clearfix"><DIV class="art-vmenublockheader"><H3 class="t">Menu</H3></DIV><DIV class="art-vmenublockcontent"><UL class="art-vmenu"><LI><A href="https://2015.igem.org/Team:UNA_Honduras" class="active">HOME</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/team.html">TEAM</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/project.html">PROJECT</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/description.html">DESCRIPTION</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/immunology-of-dengue.html">IMMUNOLOGY OF DENGUE</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/experiments-and-protocols.html">EXPERIMENTS AND PROTOCOLS</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/results.html">RESULTS</A></LI></UL><LI><A href="https://2015.igem.org/Team:UNA_Honduras/parts.html">PARTS</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/notebook.html">NOTEBOOK</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/attributions.html">ATTRIBUTIONS</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/collaborations.html">COLLABORATIONS</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/human-practices.html">HUMAN PRACTICES</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/public-outreach.html">PUBLIC OUTREACH</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/laws-regulation.html">LAWS &amp; REGULATION</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/ethics.html">ETHICS</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/media-coverage.html">MEDIA COVERAGE</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/safety.html">SAFETY</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/entrepreneurship.html">ENTREPRENEURSHIP</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/gallery.html">GALLERY</A></LI><LI><A href="https://2015.igem.org/Team:UNA_Honduras/references.html">REFERENCES</A></LI></DIV></DIV></DIV><DIV class="art-layout-cell art-content"><ARTICLE class="art-post art-article"><DIV class="art-postmetadataheader"><H2 class="art-postheader">IMMUNOLOGY OF DENGUE</H2></DIV><DIV class="art-postcontent art-postcontent-0 clearfix"><P class="MsoNormal"><B><SPAN lang="EN-US">B Cells and T Cells</SPAN></B></P><P class="MsoNormal"><SPAN lang="EN-US">Lymphocytes
are one of the five kinds of white blood cells or leukocytes), circulating in
the blood.</SPAN></P><P class="MsoNormal"><SPAN lang="EN-US">Although
mature lymphocytes all look pretty much alike, they are extraordinarily diverse
in their functions. The most abundant lymphocytes are:</SPAN></P><P class="MsoNoSpacing"><SPAN lang="EN-US">•             B lymphocytes (often simply called
B cells) and</SPAN></P><P class="MsoNoSpacing"><SPAN lang="EN-US">•             T lymphocytes (likewise called T
cells</SPAN></P><P> </P><P class="MsoNormal"><SPAN lang="EN-US"> The specificity of binding resides in a
receptor for antigen:</SPAN></P><P class="MsoNoSpacing"><SPAN lang="EN-US">•             The B cell receptor (BCR) for
antigen and</SPAN></P><P class="MsoNoSpacing"><SPAN lang="EN-US">•             The T cell receptor (TCR)
respectively.</SPAN></P><P> </P><P class="MsoNormal"><SPAN lang="EN-US">Both BCRs
and TCRs share these properties:</SPAN></P><P class="MsoNoSpacing" style="margin-left: 53.25pt; text-indent: -35.25pt;"><SPAN lang="EN-US">•                </SPAN><SPAN lang="EN-US">They
are integral membrane proteins.</SPAN></P><P class="MsoNoSpacing" style="margin-left: 53.25pt; text-indent: -35.25pt;"><SPAN lang="EN-US">•                </SPAN><SPAN lang="EN-US">They
are present in thousands of identical copies exposed at the cell surface.</SPAN></P><P class="MsoNoSpacing" style="margin-left: 53.25pt; text-indent: -35.25pt;"><SPAN lang="EN-US">•                </SPAN><SPAN lang="EN-US">They
are made before the cell ever encounters an antigen.</SPAN></P><P class="MsoNoSpacing" style="margin-left: 53.25pt; text-indent: -35.25pt;"><SPAN lang="EN-US">•                </SPAN><SPAN lang="EN-US">They
are encoded by genes assembled by the recombination of segments of DNA.</SPAN></P><P> </P><P class="MsoNormal"><SPAN lang="EN-US">How antigen
receptor diversity is generated</SPAN></P><P class="MsoNoSpacing"><SPAN lang="EN-US">•             They have a unique binding site.</SPAN></P><P class="MsoNoSpacing"><SPAN lang="EN-US">•             This site binds to a portion of the
antigen called an antigenic determinant or epitope.</SPAN></P><P class="MsoNoSpacing"><SPAN lang="EN-US">•             The binding, like that between an
enzyme and its substrate depends on     complementarity
of the surface of the receptor and the surface of the epitope.</SPAN></P><P class="MsoNoSpacing"><SPAN lang="EN-US">•             Successful binding of the antigen
receptor to the epitope, if accompanied by additional signals, results in:</SPAN></P><P class="MsoNoSpacing"><SPAN lang="EN-US">               Stimulation of the cell to leave G0
and enter the cell cycle.</SPAN></P><P class="MsoNoSpacing"><SPAN lang="EN-US">               Repeated mitosis leads to the
development of a clone of cells bearing the same antigen receptor; that is, a
clone of cells of the identical specificity.</SPAN></P><P> </P><P class="MsoNormal"><SPAN lang="EN-US">BCRs and
TCRs differ in:</SPAN></P><P class="MsoNoSpacing"><SPAN lang="EN-US">•             Their structure;</SPAN></P><P class="MsoNoSpacing"><SPAN lang="EN-US">•             The genes that encode them;</SPAN></P><P class="MsoNoSpacing"><SPAN lang="EN-US">•             The type of epitope to which they
bind.</SPAN></P><P> </P><P class="MsoNoSpacing"><B><SPAN lang="EN-US">Epitopes</SPAN></B></P><P> </P><P class="MsoNormal" style="text-align: justify;"><SPAN lang="EN-US">An epitope, also known as antigenic
determinant, is the part of an antigen that is recognized by the immune system,
specifically by antibodies, B cells, or T cells. For example, the epitope is
the specific piece of the antigen that an antibody binds to. The part of an
antibody that binds to the epitope is called a paratope.</SPAN></P><P class="MsoNormal" style="text-align: justify;"><SPAN lang="EN-US">The epitopes of protein antigens are divided
into two categories, conformational epitopes and linear epitopes, based on
their structure and interaction with the paratope. A conformational epitope is
composed of discontinuous sections of the antigen's amino acid sequence. These
epitopes interact with the paratope based on the 3-D surface features and shape
or tertiary structure of the antigen. The proportion of epitopes that are
conformational is unknown.</SPAN></P><P class="MsoNormal" style="text-align: justify;"><SPAN lang="EN-US">By contrast, linear epitopes interact with the
paratope based on their primary structure. A linear epitope is formed by a
continuous sequence of amino acids from the antigen.</SPAN></P><P class="MsoNormal" style="text-align: justify;"><SPAN lang="EN-US">T cell epitopes are presented on the surface of
an antigen-presenting cell, where they are bound to MHC molecules. In humans,
professional antigen-presenting cells are specialized to present MHC class II
peptides, whereas most nucleated somatic cells present MHC class I peptides.</SPAN></P><P class="MsoNormal" style="text-align: justify;"><SPAN lang="EN-US">MHC class I and II epitopes can be reliably
predicted by computational means alone.</SPAN></P><P class="MsoNormal" style="text-align: justify;"><SPAN lang="EN-US">Epitopes are often used in proteomics and the
study of other gene products. Using recombinant DNA techniques genetic
sequences coding for epitopes that are recognized by common antibodies can be
fused to the gene. Following synthesis, the resulting epitope tag allows the
antibody to find the protein or other gene product enabling lab techniques for
localization, purification, and further molecular characterization.</SPAN></P><P class="MsoNormal" style="text-align: justify;"><SPAN lang="EN-US" style="color: rgb(51, 49, 50); background-color: white;">Vaccination is generally considered to be the most effective method of
preventing infectious diseases. All vaccinations work by presenting a foreign
antigen to the immune system in order to evoke an immune response. The active
agent of a vaccine may be intact but inactivated (‘attenuated’) forms of the
causative pathogens (bacteria or viruses), or purified components of the
pathogen that have been found to be highly immunogenic. The increased
understanding of antigen recognition at molecular level has resulted in the
development of rationally designed peptide vaccines. The concept of peptide
vaccines is based on identification and chemical synthesis of B-cell and T-cell
epitopes which are immunodominant and can induce specific immune responses. The
accelerating growth of bioinformatics techniques and applications along with
the substantial amount of experimental data has given rise to the probability
of development new vaccines.</SPAN></P></DIV></ARTICLE></DIV></DIV></DIV></DIV></DIV><P class="art-page-footer"><SPAN id="art-footnote-links">Designed by <A href="www.bluemas.com" target="_blank">Blue+</A>.</SPAN></P></DIV></DIV></DIV></DIV></DIV></BODY></HTML>